Michael discusses the shocking affordability of rapid tests, highlighting that they can be produced for less than a dollar. He critiques the FDA's classification of these tests as medical devices, which drives up costs unnecessarily, and advocates for the government to purchase and distribute tests widely to combat the ongoing impact of the virus on public health and the economy.
